REGN vs AAPL: Which Stock is Better?
Side-by-side comparison of Regeneron Pharmaceuticals Inc and Apple Inc in 2026
REGN
Regeneron Pharmaceuticals Inc
$614.78
AAPL
Apple Inc
$271.65
Key Metrics Comparison
| Metric | REGN | AAPL | Winner |
|---|---|---|---|
| Market Cap | $65.81B | N/A | REGN |
| P/E Ratio | 15.34 | 37.63 | REGN |
| EPS (TTM) | $40.93 | $8.26 | REGN |
| Revenue Growth | 0.2% | 0.2% | REGN |
| Gross Margin | 43.9% | 47.9% | AAPL |
Analyze REGN
Full quant analysis
Analyze AAPL
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is REGN or AAPL a better investment?
Comparing REGN and AAPL: Regeneron Pharmaceuticals Inc has a market cap of $65.81B while Apple Inc has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between REGN and AAPL?
REGN (Regeneron Pharmaceuticals Inc) and AAPL (Apple Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: REGN or AAPL?
Based on P/E ratios, REGN trades at a lower multiple (15.3x vs 37.6x).
Which is growing faster: REGN or AAPL?
REGN has higher revenue growth at 0.2% vs 0.2% for AAPL.
Which company is more profitable: REGN or AAPL?
Apple Inc (AAPL) has higher gross margins at 47.9% compared to 43.9% for REGN.
Which is the larger company: REGN or AAPL?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $65.81B compared to N/A for AAPL.
Should I buy REGN or AAPL in 2026?
Both REGN and AAPL have investment merit. REGN trades at $614.78 while AAPL trades at $271.65. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between REGN and AAPL stock?
Key differences: Market Cap ($65.81B vs N/A), P/E Ratio (15.3x vs 37.6x), Revenue Growth (0.2% vs 0.2%), Gross Margin (43.9% vs 47.9%).